On 23 and 24 October, Senior Economist Kristoffer Jensen speaks at the two-days Helsinki IP Summit.
Kristoffer will discuss the value of the Intellectual Property System in boosting innovation and investments for pharmaceutical companies.
This discussion is based on our report from 2017 and 2018 titled “Study on the economic impact of the supplementary protection certificates, pharmaceutical incentives, and rewards in Europe”.
Kristoffer will be joined by another 63 speakers discussing topics on e.g. life science, health tech, and IP. All of whom are top experts within this field.
Learn more about the study
Learn more about the summit
For further information, please contact Kristoffer Jensen